当前位置：
X-MOL 学术
›
Am. J. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia
American Journal of Hematology ( IF 10.1 ) Pub Date : 2024-05-27 , DOI: 10.1002/ajh.27365 Tamer Othman 1 , Shanpeng Li 2 , Jianying Zhang 2 , Hoda Pourhassan 1 , Vaibhav Agrawal 1 , Dat Ngo 3 , Jason Chen 3 , Leonardo Farol 1 , Firoozeh Sahebi 1 , Karamjeet Sandhu 1 , Ricardo Spielberger 1 , Guido Marcucci 1 , Stephen J Forman 1 , Anthony S Stein 1 , Ryotaro Nakamura 1 , Vinod Pullarkat 1 , Matthew Mei 1 , Ibrahim Aldoss 1 , Paul Koller 1
American Journal of Hematology ( IF 10.1 ) Pub Date : 2024-05-27 , DOI: 10.1002/ajh.27365 Tamer Othman 1 , Shanpeng Li 2 , Jianying Zhang 2 , Hoda Pourhassan 1 , Vaibhav Agrawal 1 , Dat Ngo 3 , Jason Chen 3 , Leonardo Farol 1 , Firoozeh Sahebi 1 , Karamjeet Sandhu 1 , Ricardo Spielberger 1 , Guido Marcucci 1 , Stephen J Forman 1 , Anthony S Stein 1 , Ryotaro Nakamura 1 , Vinod Pullarkat 1 , Matthew Mei 1 , Ibrahim Aldoss 1 , Paul Koller 1
Affiliation
|
Improved first progression-free survival following allogeneic hematopoietic cell transplantation relapse with the use of immunotherapy.
中文翻译：
费城染色体阳性急性淋巴细胞白血病同种异体造血细胞移植后复发的结果
使用免疫疗法改善同种异体造血细胞移植复发后的首次无进展生存期。
更新日期：2024-05-27
中文翻译：
费城染色体阳性急性淋巴细胞白血病同种异体造血细胞移植后复发的结果
使用免疫疗法改善同种异体造血细胞移植复发后的首次无进展生存期。
京公网安备 11010802027423号